Brussels, 06/10/2009 (Agence Europe) - In a ruling on Tuesday 6 October 2009, the European Court of Justice ruled that the Commission must reconsider whether GlaxoSmithKline's general sales conditions in Spain can be accepted. The Commission refused to give the go-ahead to the conditions GSK wanted to apply in Spain to restrict parallel exports. In its ruling the Court confirmed the Court of First Instance's conclusions in the same case, namely that the Commission should have paid greater...